API Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (Websockets) API Financial News API Delisted Data API
Solutions
New & Popular APIs
Show all APIs Fundamental Data APIs Historical End-of-Day API Real-time Prices API Financial Events & News API Indices Historical Constituents API 40 000 Stock Market Logos API Forex Data APIs
Other products
Google Sheets Add-on Excel Add-on Coding Libraries (Python, R, etc) Wordpress Add-on
API Marketplace
Community
Academy 152 articles Forum Github 14 repos
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. OL /
  3. PCIB.OL

PCI Biotech Holding ASA (PCIB OL) stock market data APIs

kr1.28 -0.12(-8.6%) as of November 21, 2024
Price chart is built with Anychart

PCI Biotech Holding ASA, a biopharmaceutical company, focuses on the development and commercialization of novel therapies for the treatment of cancer through its photochemical internalization (PCI) technology platform. The company's technology platform consists of a proprietary small molecule photosensitiser (fimaporfin) and a light source; and develops photochemical internalisation (PCI), inducing light-triggered intracellular release for various therapeutic modalities, as well as photochemical lysis (PCL) comprising light-triggered cell lysis, which enhances yield and purity in viral vector manufacturing. It also explores for intratumoural immunotherapy therapeutics that identifies novel treatment combinations to overcome resistance to immune-checkpoint inhibitors and safety-issues associated with treatments; and develops nucleic acid therapeutics to improve the treatment of dermatological diseases. In addition, the company develops fimaVACC for immunotherapy indications, which is in pre-clinical study; fimaNAc, a nucleic acid therapeutics delivery technology, which is in pre-clinical study for bioprocessing and dermatology indications; and technology for viral vector manufacturing and pre-clinical research for intratumoural immunotherapy. PCI Biotech Holding ASA was incorporated in 2007 and is headquartered in Oslo, Norway.

PCI Biotech Holding ASA Financial Data Overview

1.402
1.28
-
1.688
1.28
1.1-3.06
52 332 K
37 326 K
5 999 K
-0.1543
1.727
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'PCIB',
Type: 'Common Stock',
Name: 'PCI Biotech Holding ASA',
Exchange: 'OL',
CurrencyCode: 'NOK',
CurrencyName: 'Norwegian Krone',
CurrencySymbol: 'kr',
CountryName: 'Norway',
CountryISO: 'NO',
OpenFigi: NULL,
ISIN: 'NO0010405640',
CIK: NULL,
EmployerIdNumber: '',
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: 'International',
Sector: 'Healthcare',
Industry: 'Biotechnology',
}

PCI Biotech Holding ASA Fundamental Data is available in our Financial Data APIs

  • Net Revenue 5 999 K
  • EBITDA -17 812 000
  • Earnings Per Share -0.42
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get PCI Biotech Holding ASA Earnings via APIs

  • Latest Release 2023-08-31
  • EPS/Forecast NaN

Get PCI Biotech Holding ASA End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get PCI Biotech Holding ASA latest news via APIs

PCI Biotech initiates field testing of its proprietary technology for gene therapy manufacturing

Oslo, Norway, 13 October 2023 – PCI Biotech (OSE: PCIB) today announced a research collaboration agreement with the aim to address critical pain points in the manufacturing of gene therapies. The p...
  • EUROPEAN REGULATORY NEWS
  • OSLO STOCK EXCHANGE:PCIB
  • PCI BIOTECH HOLDING ASA
  • REGULATORY INFORMATION

PCI Biotech: European patent for mRNA delivery with fimaNAc

Oslo (Norway), 7 September 2023 – PCI Biotech (OSE: PCIB), a biopharmaceutical company, today announces that the European Patent Office (EPO) has informed PCI Biotech that they intend to grant a new...
  • EUROPEAN REGULATORY NEWS
  • OSLO STOCK EXCHANGE:PCIB
  • PCI BIOTECH HOLDING ASA
  • REGULATORY INFORMATION
News API is available at any package from $19.99 See full price
Get sample of News API
Do you have any questions?
support@eodhistoricaldata.com